Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8278425 None

Patent 8278425 was granted and assigned to Ionis Pharmaceuticals on October, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Ionis Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8278425

Patent Inventor Names

Eric E. Swayze0

Thazha P. Prakash0

Balkrishin Bhat0

Date of Patent

October 2, 2012

Patent Application Number

12602074

Date Filed

May 22, 2008

Patent Citations Received

‌

US Patent 12129466 Compounds and methods for modulating UBE3A-ATS

‌

US Patent 12013403 Compositions and methods for detection of SMN protein in a subject and treatment of a subject

‌

US Patent 12018261 Compounds and methods for modulating factor XII

‌

US Patent 12060558 Methods and compositions for treatment of cholesteryl ester storage disease

‌

US Patent 12091662 Compositions for modulating tau expression

‌

US Patent 11661601 Methods for modulating FMR1 expression

...

Patent Primary Examiner

‌

Traviss C Mcintosh, III

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8278425 None

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API